Pacific Edge shares slumped to a five-month low and Xero plunged again as as the local stock market joined a global sell-off amid concerns high-growth companies may struggle to convert sales into profits.
Shares in the Dunedin-based bladder cancer text developer fell as much as 15 per cent to $1.04, the lowest since Oct. 23, and were recently down 6.6 per cent to $1.14. The shares have dropped 25 per cent in the past month.
Xero, whose shares soared 325 per cent last year, fell as low as $29.80 and recently traded down 9.1 per cent at $30.10. The stock soared after the Wellington-based company raised $180 million in October, selling 9.92 million shares at $18.15 apiece, but has come in for some sharp selling in the past month, dropping 31 per cent.
Xero is rated a 'sell' by two analysts and a 'buy' by a third, with a median price target of $36, according to Reuters data. Pacific Edge does not have analyst coverage yet, said Goodson.
Stocks on Wall Street sank yesterday, with the tech-heavy Nasdaq Composite Index recording its biggest daily decline since November 2011. Investors have been selling stocks in growth-orientated internet and biotech firms in recent months, cashing in gains from last year. The NZX 50 Index, which is the first major benchmark index to reopen after the US market closes, slid 1.1 per cent led by growth stocks.